Faculty of Medicine and Odontostomatology, University of Technical and Technological Sciences of Bamako (USTTB), 1805, Point G, Bamako, Mali.
University Teaching Hospital Point G, Bamako, Mali.
BMC Med Genet. 2020 Jul 3;21(1):142. doi: 10.1186/s12881-020-01072-4.
Breast cancer, the most common tumor in women in Mali and worldwide has been linked to several risk factors, including genetic factors, such as the PIN3 16-bp duplication polymorphism of TP53. The aim of our study was to evaluate the role of the PIN3 16-bp duplication polymorphism in the susceptibility to breast cancer in the Malian population and to perform a meta-analysis to better understand the correlation with data from other populations.
We analyzed the PIN3 16-bp duplication polymorphism in blood samples of 60 Malian women with breast cancer and 60 healthy Malian women using PCR. In addition, we performed a meta-analysis of case-control study data from international databases, including Pubmed, Harvard University Library, Genetics Medical Literature Database, Genesis Library and Web of Science. Overall, odds ratio (OR) with 95% CI from fixed and random effects models were determined. Inconsistency was used to assess heterogeneity between studies and publication bias was estimated using the funnel plot.
In the studied Malian patients, a significant association of PIN3 16-bp duplication polymorphism with breast cancer risk was observed in dominant (A1A2 + A2A2 vs. A1A1: OR = 2.26, CI 95% = 1.08-4.73; P = 0.02) and additive (A2 vs. A1: OR = 1.87, CI 95% = 1.05-3.33; P = 0.03) models, but not in the recessive model (P = 0.38). In the meta-analysis, nineteen (19) articles were included with a total of 6018 disease cases and 4456 controls. Except for the dominant model (P = 0.15), an increased risk of breast cancer was detected with the recessive (OR = 1.46, 95% CI = 1.15-1.85; P = 0.002) and additive (OR = 1.11, 95% CI = 1.02-1.19; P = 0.01) models.
The case-control study showed that PIN3 16-bp duplication polymorphism of TP53 is a significant risk factor for breast cancer in Malian women. These findings are supported by data from the meta-analysis carried out on different ethnic groups around the world.
乳腺癌是马里和全球女性中最常见的肿瘤,与多种风险因素有关,包括遗传因素,如 TP53 的 PIN3 16-bp 重复多态性。本研究旨在评估 PIN3 16-bp 重复多态性在马里人群中对乳腺癌易感性的作用,并进行荟萃分析以更好地理解与其他人群数据的相关性。
我们使用 PCR 分析了 60 名患有乳腺癌的马里妇女和 60 名健康马里妇女的血液样本中的 PIN3 16-bp 重复多态性。此外,我们对国际数据库中的病例对照研究数据进行了荟萃分析,包括 PubMed、哈佛大学图书馆、遗传学医学文献数据库、Genesis 图书馆和 Web of Science。使用固定效应模型和随机效应模型确定总体比值比(OR)和 95%置信区间。使用漏斗图评估异质性和发表偏倚。
在研究的马里患者中,发现 PIN3 16-bp 重复多态性与乳腺癌风险存在显著关联,在显性(A1A2+A2A2 与 A1A1:OR=2.26,95%CI=1.08-4.73;P=0.02)和加性(A2 与 A1:OR=1.87,95%CI=1.05-3.33;P=0.03)模型中,但在隐性模型中没有(P=0.38)。荟萃分析中,纳入了 19 篇文章,共包含 6018 例疾病病例和 4456 例对照。除显性模型(P=0.15)外,还发现隐性(OR=1.46,95%CI=1.15-1.85;P=0.002)和加性(OR=1.11,95%CI=1.02-1.19;P=0.01)模型中乳腺癌风险增加。
病例对照研究表明,TP53 的 PIN3 16-bp 重复多态性是马里女性乳腺癌的一个重要危险因素。这些发现得到了对全球不同种族人群进行荟萃分析的数据支持。